By Dr. Prakash Saini
On World Ovarian Cancer Day, the conversation across Kenya’s oncology landscape is shifting from late-stage treatment to earlier detection, precision diagnostics and integrated care pathways. At the centre of this transformation is the Nairobi West Hospital, which is steadily positioning itself as a key private-sector driver of innovation in cancer management.
Ovarian cancer remains one of the most challenging gynaecological cancers in Kenya, often diagnosed late due to non-specific symptoms and limited routine screening tools. National data shows that many patients still present at advanced stages, a reality that continues to drive high mortality rates among women despite growing awareness efforts and expanding oncology services across the country.
Against this backdrop, The Nairobi West Hospital has in recent years strengthened its clinical and technological capacity in oncology, particularly in diagnostics and molecular imaging. A major milestone has been the establishment of advanced nuclear medicine capability through the acquisition of a cyclotron and the local production of radioisotopes used in cancer imaging and treatment planning. This development has significantly reduced reliance on imported tracers, improving turnaround times for PET/CT imaging and enhancing staging accuracy for complex cancers, including ovarian malignancies.
Hospital clinicians note that improved imaging precision is directly influencing treatment pathways—allowing earlier identification of metastasis, more accurate surgical planning, and better monitoring of response to chemotherapy. In ovarian cancer care, where disease progression is often silent, this level of diagnostic clarity is increasingly critical.
Beyond infrastructure, The Nairobi West Hospital has also integrated digital imaging systems and artificial intelligence-assisted interpretation tools in oncology workflows. These technologies are helping multidisciplinary teams refine diagnosis and personalise treatment decisions, aligning with global trends in precision medicine.
However, clinicians caution that technology alone is not enough. The persistent challenge in ovarian cancer remains delayed presentation, often due to low awareness of symptoms such as persistent bloating, pelvic pain, early satiety and urinary frequency. Strengthening community education and referral systems remains central to improving outcomes.
Across Kenya’s broader health system, the oncology landscape is evolving rapidly. Cancer incidence continues to rise, with national estimates placing annual cases in the tens of thousands, driven by improved detection and changing risk profiles. Yet, access gaps remain, particularly in specialised diagnostics, oncology workforce distribution and affordability of care.
Health technology is emerging as a key equaliser. From digital pathology to AI-supported radiology and tele-oncology consultations, hospitals are increasingly adopting tools that extend specialist expertise beyond urban centres. Nairobi West Hospital’s investment in molecular imaging and radiopharmaceutical production reflects this broader shift toward self-sufficiency and innovation-led care.
At the same time, experts are calling for stronger integration between private and public oncology services, improved data systems for cancer tracking, and expanded genetic testing for high-risk populations—particularly women with a family history of breast or ovarian cancer.
As the world marks Ovarian Cancer Day, the message from clinicians is clear: early detection remains the most powerful tool against the disease. But equally important is the continued investment in diagnostic innovation, workforce training and equitable access to advanced care.
For The Nairobi West Hospital, the focus is now on deepening clinical excellence while scaling technologies that make earlier, more precise cancer diagnosis not just possible—but routine.
The writer is Medical Superintendent, The Nairobi West Hospital